Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039767 | SCV000063456 | uncertain significance | not specified | 2016-03-14 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The p.Arg1909His va riant in PCDH15 has been identified by our laboratory in one individual with hea ring loss who did not have a second PCDH15 variant. This variant has also been i dentified in 14/121438 chromosomes by the Exome Aggregation Consortium (ExAC, ht tp://exac.broadinstitute.org; dbSNP rs145851144). Computational prediction tools and conservation analyses suggest that the p.Arg1909His variant may not impact the protein, though this information is not predictive enough to rule out pathog enicity. In summary, while the clinical significance of the p.Arg1909His variant is uncertain, these data suggest that it is more likely to be benign. |
Counsyl | RCV000671807 | SCV000796828 | uncertain significance | Usher syndrome type 1F | 2018-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001548684 | SCV001768639 | uncertain significance | not provided | 2025-01-24 | criteria provided, single submitter | clinical testing | Reported in published literature (as R1889H using alternate nomenclature) as a single heterozygous variant in a patient with retinitis pigmentosa who had a different suggested genetic etiology for the phenotype (PMID: 25692139); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25692139) |
Labcorp Genetics |
RCV001548684 | SCV003274562 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000671807 | SCV002080030 | uncertain significance | Usher syndrome type 1F | 2020-02-03 | no assertion criteria provided | clinical testing |